# Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

> **NCT01216163** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 218 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Novel Ibuprofen
- **DRUG:** Acetaminophen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01216163
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2012-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01216163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01216163, "Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01216163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*